Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;35(8):1096-100.
doi: 10.1002/hed.23085. Epub 2012 Jul 17.

Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study

Affiliations

Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study

Samir S Khariwala et al. Head Neck. 2013 Aug.

Abstract

Background: Head and neck squamous cell carcinoma (HNSCC) is associated with tobacco use. Still, most smokers do not develop HNSCC. The mechanisms of varying susceptibility to HNSCC are poorly studied to date. Tobacco metabolite research provides insight regarding the innate metabolism and excretion of carcinogens.

Methods: Smokers with HNSCC (cases) were compared with smokers without HNSCC (controls) in a matched cohort. The tobacco metabolites studied were: 1-hydroxypyrene (1-HOP), N'-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).

Results: In 33 subjects, mean 1-HOP was 1.82 pmol/mg creatinine versus 1.08 pmol/mg creatinine (p = .004) and mean NNN was 0.10 pmol/mg creatinine versus 0.04 pmol/mg creatinine (p = .01) in cases and controls, respectively. NNAL did not differ between groups.

Conclusions: Smokers with HNSCC have elevated urinary levels of 1-HOP and total NNN compared with matched controls, suggesting an increased effective exposure to these carcinogens. Tobacco constituent metabolites may be useful in understanding tobacco-related carcinogenesis in HNSCC.

Keywords: biomarkers; carcinogenesis; head and neck cancer; metabolites; tobacco.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Scatterplot of 1-hydroxypyrene (1-HOP) in study (blue dot) and control (red dot) subjects. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 2
FIGURE 2
Scatterplot of nitrosonornicotine (NNN) in study (blue dot) and control (red dot) subjects. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 3
FIGURE 3
Scatterplot of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in study (blue dot) and control (red dot) subjects. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

References

    1. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr, Doll R. Mortality from smoking worldwide. Br Med Bull. 1996;52:12–21. - PubMed
    1. World Health Organization. Tobacco or health: a global status report. Geneva: World Health Organization; 1997.
    1. Schlecht NF, Franco EL, Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers in the upper aerodigestive tract in Brazil. Epidemiology. 1999;10:412–418. - PubMed
    1. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86:131–137. - PubMed
    1. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004;31:726–733. - PubMed

Publication types